SCHEMBL5316612

SCHEMBL5316612

CS(=O)(=O)N(c1ccnc(F)n1)c1nc(-c2ccccc2)ncc1C(N)=O

nearest known ligand 0.43

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PDE4B Q07343 9/20 0.43
ALDH1A1 P00352 4/20 0.40
SMN1; SMN2 Q16637 3/20 0.40
MEN1 O00255 4/20 0.39
KMT2A Q03164 4/20 0.39
KDM4E B2RXH2 1/20 0.38
MAPT P10636 4/20 0.36
NPC1 O15118 1/20 0.36
TP53 P04637 1/20 0.36
RAB9A P51151 1/20 0.36
SGK1 O00141 1/20 0.36
LMNA P02545 2/20 0.35
CYP1A2 P05177 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
MAPK1 P28482 1/20 0.35
ATM Q13315 1/20 0.35
HPGD P15428 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5914453 0.85 ALDH1A1 (0.45) PDE4BALDH1A1SMN1; SMN2MEN1KMT2A
SCHEMBL12929707 0.73 ALDH1A1 (0.66) PDE4BALDH1A1SMN1; SMN2MEN1KMT2A
SCHEMBL5264668 0.72 PDE4B (0.56) PDE4BALDH1A1MEN1KMT2AMAPT
SCHEMBL5914102 0.69 ALDH1A1 (0.40) ALDH1A1SMN1; SMN2MEN1KMT2AKDM4E
SCHEMBL5265201 0.66 PDE4B (0.60) PDE4BALDH1A1SMN1; SMN2MEN1KMT2A
SCHEMBL4560197 0.65 ALDH1A1 (0.63) PDE4BALDH1A1SMN1; SMN2MEN1KMT2A
SCHEMBL4669727 0.65 MEN1 (0.54) ALDH1A1SMN1; SMN2MEN1KMT2AMAPT
Hydrochloric Acid SCHEMBL30227955 0.64 PDE4B (0.51) PDE4BALDH1A1SMN1; SMN2MEN1KMT2A
SCHEMBL8294634 0.63 ALDH1A1 (0.69) ALDH1A1SMN1; SMN2MEN1KMT2AKDM4E
SCHEMBL28103573 0.63 PDE4B (0.77) PDE4BALDH1A1MEN1KMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1794135-A1 SUBSTITUTED HETEROCYCLIC COMPOUNDS AND METHODS OF USE Amgen Inc. (US) 2007-06-13 EP disclosed
WO-2006037117-A1 SUBSTITUTED HETEROCYCLIC COMPOUNDS AND METHODS OF USE AMGEN INC. (US) 2006-04-06 WO disclosed